Description
Anti-CEACAM5 (Labetuzumab) -CL2A-SN-38 ADC | ADC-W-382 | Gentaur UK, US & Europe Distribution
Short Description: This ADC product is comprised of an anti-CEACAM5 monoclonal antibody conjugated via a CL2A linker to a SN-38
Status: In stock
Expected Delivery Time: 9-11Weeks